Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts

Gene Therapy
M M HuangD B Kohn

Abstract

Hurler syndrome (mucopolysaccharidosis IH or MPS IH) is a congenital mucopolysaccharide storage disorder resulting from a genetic deficiency of alpha-L-iduronidase (IDUA), which is required for lysosomal degradation of glycosaminoglycans heparan sulfate and dermatan sulfate. Even though histocompatible bone marrow transplantation has been applied for the treatment of Hurler syndrome, gene therapy via autologous bone marrow transplantation (BMT) may be more beneficial for this disease. Two retroviral vectors containing a full-length human IDUA cDNA were constructed using Moloney murine leukemia virus (MoMLV)-based vector backbones. High-titer vector-producing clones containing the L-HuID-SN and MFG-HuID retroviral vectors were established. The efficiency of gene transfer into primitive human CD34+ hematopoietic cells using both retroviral vectors is in the range of 18-23%. The level of enzyme expression in transduced primary bone marrow cells was increased 40- to 50-fold compared with that of sham-transduced cells. Enzyme produced by the progeny of the transduced human CD34+ cells carrying IDUA cDNA corrected Hurler fibroblasts via mannose-6-phosphate receptors. These findings suggest that genetically modified hematopoietic prog...Continue Reading

Citations

Jan 26, 2006·Journal of Inherited Metabolic Disease·M CamassolaN B Nardi
Sep 2, 2003·Molecular Genetics and Metabolism·Yi ZhengElizabeth F Neufeld
Jun 6, 2002·European Journal of Biochemistry·Paola Di NataleLuigi Naldini
Apr 4, 2002·Drugs·Raphael Schiffmann, Roscoe O Brady
Feb 5, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ed J WraithDoug A Brooks
Apr 12, 2001·Journal of Internal Medicine·D B Kohn
Jul 5, 2005·Expert Opinion on Investigational Drugs·T M Daly, M S Sands
Nov 4, 2015·Trends in Cell Biology·Michael G DanielKateri A Moore
Apr 18, 2008·World Journal of Gastroenterology : WJG·Xi JinYou-Ming Li
Dec 11, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hee-Kyung Jin, Edward H Schuchman
Jul 1, 2021·Journal of Inherited Metabolic Disease·Sarah C HurtDavid T Curiel

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.